Two-drug immunotherapy deemed safe for lung cancer patients, study shows
Thursday, June 2, 2016 - 10:31
in Health & Medicine
Utilizing the immunotherapeutic agents nivolumab and ipilimumab could lead to more effective treatment options for non-small cell lung cancer patients who fail initial therapy, report scientists.